ArticleQuantitative biology (Beijing, China)2025
A perspective on developing foundation models for analyzing spatial transcriptomic data.
Article in Quantitative biology (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Tumor microenvironment-specific nanomedicine: from biology-driven to multi-omics-guided precision engineering.Journal of hematology & oncology · 2026Review
- Applications of large-scale artificial intelligence models in bioinformatics.Quantitative biology (Beijing, China) · 2026Review
- A perspective on developing foundation models for analyzing spatial transcriptomic data.Quantitative biology (Beijing, China) · 2025Article
- AI for Scientific Discovery in Omics Data-Driven Precision Medicine.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Do we need a foundation model (FM) for spatial transcriptomic analysis? To answer this question, we prepared this perspective as a primer. We first review the current progress of developing FMs for modeling spatial transcriptomic data and then discuss possible tasks that can be addressed by FMs. Finally, we explore future directions of developing such models for understanding spatial transcriptomics by describing both opportunities and challenges. In particular, we expect that a successful FM should boost research productivity, increase novel biological discoveries, and provide user-friendly access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.